Public participation in assessing gene technology
We rigorously assess each application to release a GMO into the environment for risk to human health and safety and the environment. This involves writing a risk assessment and risk management plan (RARMP).
A RARMP is open to submission of comments for a minimum of 30 days. Experts, stakeholders and any member of the community can comment on a RARMP.
We advertise when a RARMP is ready for comment in the Government Notices Gazette, in newspapers and on this website. You can also subscribe to be notified by email.
All comments are taken into consideration before the Gene Technology Regulator makes a decision about the application.
Open for consultation
The following DIR applications are under consideration and open for public consultation.
| Licence number | Project title | Organisation | Closing date |
|---|---|---|---|
Clinical trial of GM vaccinia virus for the treatment of solid tumours |
Novotech Pty Ltd |
||
Limited and controlled release of sorghum genetically modified for altered reproduction from sexual to asexual |
The University of Queensland |
||
Clinical trials of controlled infection with seasonal Influenza viruses |
Doherty Clinical Trials Ltd (DCT) |
We are committed to making applications for licences and the subsequent risk assessments available to anyone who wants to see them. Contact us to get copies of any application for release of a GMO into the environment. You can also view the risk assessments we prepare for these applications.
We also occasionally ask for public comment on other matters such as proposed changes to the Regulator’s guidelines and policy documents, and reviews of the legislation.
Subscribe to OGTR news
Let us automatically notify you about:
- new licence applications for the release of GMOs into the environment
- public consultations
- significant changes to legislation.